Do patients with oral and oropharyngeal squamous cell carcinoma benefit from elective contralateral neck dissection? A long-term analysis by Lanzer, M et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2012
Do patients with oral and oropharyngeal squamous cell carcinoma benefit
from elective contralateral neck dissection? A long-term analysis
Lanzer, M; Zemann, W; Lübbers, T H; Kruse, A; Reinisch, S
Abstract: OBJECTIVES: Oral and oropharyngeal squamous cell carcinoma puts the patient at risk for
bilateral neck lymph node metastasis. For this reason, routine bilateral neck dissection is preferred by
some surgeons as the treatment of choice, even in N0-necks, despite the morbidity of this procedure.
METHODS: Utilising data of 496 patients with squamous cell carcinoma of the head and neck region
treated at the Department of Otorhinolaryngology and Head and Neck at the Medical University Hospital,
Graz from 1999 to 2009, we retrospectively evaluated the effect of bilateral neck dissection on recurrence-
free and overall survival rates in patients with oral and oropharyngeal cancer. RESULTS: Long-term
survival of 152 patients with oral and oropharyngeal cancer did not show a statistical benefit of elective
contralateral neck dissection in patients with contralateral clinically negative neck. Neither locoregional
recurrence-free survival nor overall survival rates differed. CONCLUSION: We could not find a statistical
benefit for operating on patients with oral and oropharyngeal squamous cell carcinoma with an elective
neck dissection in contralateral clinically negative neck.
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-70818
Published Version
Originally published at:
Lanzer, M; Zemann, W; Lübbers, T H; Kruse, A; Reinisch, S (2012). Do patients with oral and oropha-
ryngeal squamous cell carcinoma benefit from elective contralateral neck dissection? A long-term analysis.
Head Neck Oncology, 4(3):70.
Page 1 of 6
Co
m
pe
ti
ng
 in
te
re
st
s:
 n
on
e 
de
cl
ar
ed
. C
on
fli
ct
 o
f i
nt
er
es
ts
: n
on
e 
de
cl
ar
ed
.
A
ll 
au
th
or
s 
co
nt
ri
bu
te
d 
to
 t
he
 c
on
ce
pti
on
, d
es
ig
n,
 a
nd
 p
re
pa
ra
ti
on
 o
f t
he
 m
an
us
cr
ip
t,
 a
s 
w
el
l a
s 
re
ad
 a
nd
 a
pp
ro
ve
d 
th
e 
fin
al
 m
an
us
cr
ip
t.
A
ll 
au
th
or
s 
ab
id
e 
by
 t
he
 A
ss
oc
ia
ti
on
 fo
r 
M
ed
ic
al
 E
th
ic
s 
(A
M
E)
 e
th
ic
al
 r
ul
es
 o
f d
is
cl
os
ur
e.
Original research study
For citation purposes: Lanzer M, Zemann W, Lübbers T, Kruse A, Reinisch S. Do patients with oral and oropharyngeal 
squamous cell carcinoma benefit from elective contralateral neck dissection? A long-term analysis. Head Neck Oncol. 
2012 Oct 31;4(3):70.
Licensee OA Publishing London 2012. Creative Commons Attribution License (CC-BY)
Abstract
Objectives
Oral and oropharyngeal squamous 
cell carcinoma puts the patient at risk 
for bilateral neck lymph node metas-tasis. For this reason, routine bilat-
eral neck dissection is preferred by some surgeons as the treatment of 
choice, even in N0-necks, despite the morbidity of this procedure.
Methods
Utilising data of 496 patients with squamous cell carcinoma of the 
head and neck region treated at the 
Department of Otorhinolaryngology 
and Head and Neck at the Medical 
University Hospital, Graz from 1999 
to 2009, we retrospectively evaluated 
the effect of bilateral neck dissection 
on recurrence-free and overall sur-
vival rates in patients with oral and oropharyngeal cancer.
Results
Long-term survival of 152 patients with oral and oropharyngeal cancer 
did not show a statistical benefit of 
elective contralateral neck dissection in patients with contralateral clini-
cally negative neck. Neither locore-
gional recurrence-free survival nor 
overall survival rates differed.
Conclusion
We could not find a statistical benefit for operating on patients with oral and oropharyngeal squamous cell 
carcinoma with an elective neck dis-section in contralateral clinically neg-
ative neck.
Do patients with oral and oropharyngeal squamous cell carcinoma 
benefit from elective contralateral neck dissection?  
A long-term analysis
M Lanzer*, W Zemann, TH Lübbers, A Kruse, S Reinisch
Introduction
In most countries, the 5-year overall 
survival rate for oral cavity and oro-
pharyngeal cancer is around 50%1. Poor prognosis is most of the time due 
to neck lymph node metastasis. Oral 
squamous cell carcinoma (SCC) and 
oropharyngeal cancer have a high in-
cidence of cervical micrometastasis contralaterally because of the rich lym-phatic intercommunications across the midline2. Woolgar et al. demon-
strated that in patients with oral cavity or oropharyngeal tumours, bilateral 
positive neck metastasis occurred in 
6% and solely contralateral metasta-
sis in 0.4% patients3. In oral cavity 
tumours, Kurita et al. found an inci-dence of contralateral lymph node 
metastasis in 14.7% of their patients4. 
The possibility of occult contralateral 
neck lymph node metastasis in the 
oral cavity and oropharyngeal SCC requires a challenging decision—
whether the contralateral neck should 
be electively treated or not. This is es-
pecially so as some authors have stated 
that routine treatment of oral cavity and oropharyngeal tumour with bilat-
eral neck dissection (ND) is an over-treatment, resulting in higher rates of morbidity and patient discomfort5–7.
The study’s purpose is to address 
the following question: among pa-
tients with oral cavity and oropha-
ryngeal SCC, does elective bilateral 
ND, when compared with patients 
treated solely on the ipsilateral neck, reduce the frequency of recurrence 
and increase overall survival? The hy-
pothesis of this study is as following: 
does ipsilateral ND in these patients offer a sound concept without in-creased recurrence rate or decreased 
overall survival rate? The specific aim 
of this study is to compare the dis-
ease-free and overall survival rates at 
5 years between the patient cohorts and to identify patients suffering from contralateral lymph node recur-rence.
Materials and methods
Study design: The investigators built 
a retrospective patient cohort study.
Study sample: The study sample 
was derived from a population of pa-tients who presented to the 
Department of Otorhinolaryngology 
and Head and Neck (ORL) at the 
Medical University Hospital, Graz for 
treatment of an oral cavity or oropha-
ryngeal SCC between 1 January, 1999 
and 31 December, 2009. Subjects eli-
gible for study inclusion had a SCC of 
the oral cavity or oropharynx with 
contralateral clinically negative neck, 
and these subjects had undergone 
operative resection of primary with 
or without adjacent adjuvant radio-
therapy. Subjects were excluded from 
the study in case they had SCC at a 
location other than the oral cavity or oropharyngeal region, histological 
findings other than SCC, distant me-
tastasis before ND, and patients not 
treated initially at the ORL at the 
Medical University Hospital, Graz. Patients undergoing a contralateral 
ND for contralateral clinically positive 
neck were also excluded.
Study variables: The study vari-
ables included age, sex, location of 
tumour, tumour size and grade, neck lymph node status, number of posi-
tive lymph nodes and histological fac-
tors (haemangiosis, lymphangiosis, capsule penetration, perineural 
invasion and conglomerate lymph 
nodes).
* Corresponding author 
Email: martin.lanzer@usz.ch
University Hospital of Zurich, Clinic for Cranio-
Maxillofacial Surgery, Frauenklinikstrasse 24, 
CH-8091 Zürich, Switzerland 
For citation purposes: Lanzer M, Zemann W, Lübbers T, Kruse A, Reinisch S. Do patients with oral and oropharyngeal 
squamous cell carcinoma benefit from elective contralateral neck dissection? A long-term analysis. Head Neck Oncol. 
2012 Oct 31;4(3):70.
Page 2 of 6
Co
m
pe
ti
ng
 in
te
re
st
s:
 n
on
e 
de
cl
ar
ed
. C
on
fli
ct
 o
f i
nt
er
es
ts
: n
on
e 
de
cl
ar
ed
.
A
ll 
au
th
or
s 
co
nt
ri
bu
te
d 
to
 t
he
 c
on
ce
pti
on
, d
es
ig
n,
 a
nd
 p
re
pa
ra
ti
on
 o
f t
he
 m
an
us
cr
ip
t,
 a
s 
w
el
l a
s 
re
ad
 a
nd
 a
pp
ro
ve
d 
th
e 
fin
al
 m
an
us
cr
ip
t.
A
ll 
au
th
or
s 
ab
id
e 
by
 t
he
 A
ss
oc
ia
ti
on
 fo
r 
M
ed
ic
al
 E
th
ic
s 
(A
M
E)
 e
th
ic
al
 r
ul
es
 o
f d
is
cl
os
ur
e.
Original research study
Licensee OA Publishing London 2012. Creative Commons Attribution License (CC-BY)
Points of interest: The points of in-
terest were the overall 5-year sur-
vival rate as the primary endpoint 
and the 5-year, locoregional recur-
rence-free survival rate as the sec-ondary endpoint.
Treatment plan: A treatment plan was made which included the type 
and extent of unilateral or bilateral 
ND, post-operative adjuvant radiother-
apy and type of tentative chemother-
apy. If bilateral ND was performed, it was mainly because of the tumour 
size (>T3), if the primary tumour was 
close to the midline and/or positive 
lymph node status (>pN2a) on the ip-
silateral neck. ND performed in the 
contralateral neck was suprahyoidal 
or supraomohyoidal ND in case of 
oral cavity carcinoma and supraomo-
hyoidal or lateral selective ND in case of oropharyngeal carcinoma.
Radiotherapy, if applied, was 60 Gy 
in patients with negative resection 
margin and 66 Gy in patients with 
positive resection margin. The neck itself was radiated bilaterally with a 
dosage of 50 Gy. The first-choice che-motherapeutic agent was cisplatin. In case of complications such as ad-
vanced age or kidney malfunction, carboplatin was administered.Data collection, management and 
analysis: Data were collected and processed by building a tumour data-
base using Microsoft Access as the 
platform. Since data were docu-mented in a standardised procedure, all data were obtainable.
Descriptive statistics (mean, fre-
quency and range) were computed 
for each study variable. Bivariate 
analyses (c2, t test) were computed to measure the association between 
any two variables of interest. A 
log-rank test as well as the Kaplan–
Meier method was used for survival analysis.
The study design was approved 
by the Institutional Ethic Committee 
and fulfilled the guidelines of the 
Declaration of Helsinki about Ethical 
Principles for Medical Research 
Involving Human Subjects.
Results
Patients: From 1999 until 2009, 496 
patients were treated for SCC of the 
head and neck region at the ORL at 
the Medical University Hospital, Graz, 
Austria. Sixty-eight patients with his-
tologically proven SCC of the oral cav-
ity and 84 patients with SCC of the 
oropharynx with contralateral clini-
cally negative neck were analyzed in this study. Details of patient included 
in this study are shown in Table 1. 
One hundred twenty-eight patients 
underwent ipsilateral ND only (‘ob-
servation group’) and 24 patients 
were treated with elective contralat-
eral ND (‘elective ND group’).
Follow-up: The mean follow-up pe-
riod was 58 months. Since follow-up 
started in 1999, some patients were 
followed-up for >10 years.
Group comparability: At the time of initial surgical treatment, the age 
of the patients in the observation and 
elective ND groups was 64 and 60 
years, respectively. Sixty-eight and 84 patients had a primary tumour mani-
festation in the oral cavity and oro-
pharyngeal region, respectively. 
There was no significant difference in the c2 test results between the two 
groups for all analysed variables. The 
distribution of the negative resection margin between the two groups was 
even. In the observation and elective 
ND groups, 59 (46.1%) and 13 
(54.2%) patients, respectively, were 
treated with post-operative radio-
therapy. In 15 patients (11.7%) of the 
observation group and 4 patients 
(16.7%) of the elective ND group, ra-diochemotherapy was administered 
(Table 2). 
ND: Twenty-four patients under-
went elective ND of the contralateral 
N0-neck. In 1 of 24 (4%) patients, oc-
cult cervical lymph node metastasis 
was found in the contralateral neck; 
this patient was a 55-year-old male 
with a T2 poorly differentiated SCC of the lateral pharyngeal wall. 
There was no statistical difference in the c2 test results between the two groups with regard to resection 
margin, adjuvant therapy or type of 
ND (Table 2). 
Recurrence-free survival: The 5-year, 
recurrence-free survival rate for the 
observation and elective ND groups 
was 66% and 59%, respectively, and 
the 5-year locoregional (lymph node) 
recurrence-free survival rate was 89% 
and 90%, respectively (Figure 1). 
Overall survival: The 5-year overall 
survival rate was 70% in the observa-
tion arm and 72.5% in the elective 
ND arm (Figure 2). Despite the ad-
vanced tumour stages in our patients, 
101 of 152 (66.4%) patients did not 
experience any recurrence during the study period. 
Recurrence: Eighty-seven of 124 
(70.2%) patients in the observation 
group and 14 of 24 (58.3%) in the 
elective ND group did not experience 
any recurrence (Table 3). In the ob-
servation group, of those 11 patients suffering lymph node recurrence, 
5 patients (45.5%) did not receive 
adjuvant therapy and 6 patients 
(54.5%) received adjuvant radiother-
apy. One patient with distant metas-
tasis did not receive adjuvant therapy, 
10 patients received radiotherapy 
and 2 received radiochemotherapy. 
In the elective ND group, 1 patient with lymph node recurrence did not 
receive adjuvant therapy, while the 
other patient received adjuvant radio-
therapy. Both patients with distant 
metastasis did not receive adjuvant radiotherapy or radiochemotherapy.
One patient experienced a locore-gional lymph node recurrence in the 
contralateral neck; this patient had a 
pT1 SCC of the lateral tip of the tongue, 
moderately differentiated with 4 ipsi-
lateral positive lymph nodes, which 
were excised with a modified radical 
ND. Resection margins were negative; 
nevertheless, post-operative radiother-
apy was administered. Seven months after primary treatment, recurrence 
was observed in the primary region, 
level 1–4 ipsilateral, level 2 contralat-
eral, as well as distant metastasis. This 
patient had a tumour-related death 12 months after primary treatment.
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Discussion
The purpose of this study was to ad-dress the problem of occult contralat-
eral neck lymph node metastases in 
patients with SCC of the oral cavity 
and oropharyngeal region. The hy-pothesis of this study was that bilat-
eral ND in patients with contralateral 
clinically negative neck does not lead 
to an overall better survival or lower locoregional lymph node metastases 
compared to a wait-and-see proce-dure on the contralateral side. 
Specific endpoints were 5-year lo-
coregional recurrence-free survival 
and 5-year overall survival; these endpoints were compared between the two different treatment options. 
The results of this study confirm 
the hypothesis that elective treatment 
of contralateral clinically negative 
neck in patients with oral cavity or 
oropharyngeal SCC does not offer a 
higher locoregional recurrence-free 
survival rate or better overall sur-
vival rate. The 5-year overall survival 
rates were 65% and 62%, respectively 
(p = 0.971). Based on the results of 
this study and as known from other studies associated with higher mor-bidity5–7, the benefit of bilateral ND is negligible.
Risk factors for contralateral lymph node metastasis, which are a topic of debate in the literature, in-
clude tumour size, type of invasion, tumours crossing the midline, lym-phangiosis and ipsilateral lymph 
node status. As per the literature, tu-mours crossing the midline are a pre-
dictive factor for contralateral neck disease8–10. Ipsilateral positive lymph 
neck node status is expected to put 
the patient at a higher risk of contra-
lateral lymph neck node metasta-sis8–11. The debate regarding the risk 
of tumour size and grade on contra-
lateral neck involvement is contro-
versial. Some authors could 
demonstrate the statistical signifi-cance of tumour grade12,13 and 
size9,10,13–15, but in other studies, these 
risk factors were found to be insig-
nificant16,17. With the mode of 
Table 1 Demographic data of 152 patients who were included in the 
study and separated into two groups representing two different treatment 
options: observation or elective contralateral ND for patients with a clinically 
contralateral negative neck
Treatment of contralateral neck
Observation Elective contralateral ND
Count Column N (%) Count Column N (%)
Age Mean = 64 Mean = 60
Gender 
Male
Female
100
 28
78.1
21.9
19
 5
 79.2
 20.8
Localisation
Oral cavity
Oropharynx
 56
 72
43.8
56.3
12
12
 50.0
 50.0
Classification
PT1
PT2
PT3
PT4
 42
 48
 21
 17
32.8
37.5
16.4
13.3
 6
 9
 6
 3
 25.0
 37.5
 25.0
 12.5
Differentiation
Well-differentiated
Moderately-differentiated
Poorly-differentiated
  8
 46
 74
 6.3
35.9
57.8
 1
13
10
  4.2
 54.2
 41.7
Lymph node status
pN0
pN1
pN2
pN3
 49
 19
 56
  4
38.3
14.8
43.8
 3.1
14
 0
10
 0
 58.3
0
 41.7
0.0
Positive lymph nodes
0
1
2–5
>5
 49
 37
 32
 10
38.3
28.9
25.0
 7.8
14
 3
 5
 2
 58.3
 12.5
 20.8
  8.3
Perineural invasion
No
Yes
116
 12
90.6
 9.4
24
 0
100.0
0.0
Lymphangiosis
No
Yes
122
  6
95.3
 4.7
24
 0
100.0
0.0
Haemangiosis
No
Yes
124
  4
96.9
 3.1
24
 0
100.0
0.0
Capsule penetration
No
Yes
106
 22
82.8
17.2
19
 5
 79.2
 20.8
Conglomerate lymph nodesa
No
Yes
117
 11
91.4
 8.6
22
 2
 91.7
  8.3
aBulk of lymph nodes in which single lymph nodes cannot be separated histologically from each other
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issue is important, especially because ultrasound diagnostic imaging and computed tomography scannings are 
not sensitive enough to sufficiently detect occult disease18.In a recent study by Fan et al. 
(2011), all indications for contralat-
eral elective ND in oropharyngeal 
SCC were summarised as leading to: 
(1) tumours crossing the midline, (2) 
advanced staging (cT34), (3) primary tumour >3.75 mm thick, (4) multiple 
ipsilateral node involvement and (5) tumours arising in the base of the 
tongue and floor of the mouth. In case of oropharyngeal carcinoma, carcino-mas of the tonsillar fossa starting with 
a T2 classification and carcinomas of the soft palate, base of the tongue and pharyngeal wall at any stage showed a high frequency of bilateral metasta-
ses. Therefore, all three (soft palate, base of the tongue and pharyngeal 
wall) carcinomas should therefore be 
treated with bilateral ND19.Interestingly, despite facing a high number of occult lymph node metastasis in the ipsilateral and con-
tralateral neck in oral cavity and oro-pharyngeal cancer, the locoregional recurrence rate seems to be low. 
Moncrieff et al.20 experienced an 
overall locoregional lymph node re-
currence in 8% bilateral and 2% 
solely in the contralateral neck (T1 or 
T2 oropharyngis, any N). Considering that only 1 patient was treated bilat-
erally and 22 of 92 patients did not 
receive lymphadenectomy at all, re-
currence rates of 8% bilateral and 
2% solely in the contralateral neck 
appear to be very small.
Ten of 155 patients experienced a lymph node recurrence in a rece 
nt study by Sklenicka et al.21. This was similar to Lim et al.22 reporting 25 of 
230 patients with a recurrence in the 
neck. Unfortunately, the number and type of lymphadenectomy in those patients with lymph node recurrence was not described in those studies. In 
a retrospective study, Gonzalez-
Garcia et al.23 investigated 315 pa-
tients with oral cavity cancer, of whom, 
Table 2 Distribution of treatment options between the observation and 
elective contralateral ND groups
Treatment of clinical contralateral N0-neck
Observation Elective contralateral 
ND
Count Column N (%) Count Column N (%)
Resection margin
R0
R+
101
 27
78.9
21.1
20
 4
83.3
16.7
Adjuvant radiotherapy
No
Yes
 55 
 73
43.0 
57.0
13 
11
54.2
45.8
Type of neck dissection
Radical ND
Modified radical ND
Selective ND
Posterolateral ND
Supraomohyoidal ND
Expanded supraomohyoidal ND
Lateral selective ND
Suprahyoidal ND
Expanded lateral selective ND
 17
 40
  7
 27
 16
 16
  3
  2
  0
13.3
31.3
 5.5
21.1
12.5
12.5
 2.3
 1.6
 0.0
 5
 9
 1
 2
 3
 3
 0
 1
 0
20.8
37.5
 4.2
 8.3
12.5
12.5
 0.0
 4.2
 0.0
1.0
0.8
0.6
0.4
0.2
0.0
Lo
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Figure 1: Locoregional recurrence-
free survival considering contralateral 
neck treatment.
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Figure 2: Overall survival consider-
ing contralateral neck treatment.
tumour invasion as a predictive fac-
tor, Goerkem et al.13 did not observe a 
significant role in contralateral neck 
metastases, unlike in lymphangiosis. 
However, An et al.12 demonstrated the importance of type and depth of 
tumour invasion. In our patients, con-
tralateral ND was performed mainly 
due to capsule penetration, size of primary tumour, tumour crossing the 
midline or extensive ipsilateral neck 
involvement. In these situations, con-
tralateral ND was considered but not consequently conducted.
Because of the aforementioned 
risk factors, discussion on the benefit 
of contralateral elective ND is ongo-ing. Further, because the guidelines 
and to the best of our knowledge, studies comparing the two treatment 
options do not exist, investigating this 
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